eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatitis d |
| Symptom | C0009450|infection |
| Sentences | 12 |
| PubMedID- 21854665 | Hepatitis b; sometimes co-infection with hepatitis d. |
| PubMedID- 24915064 | Co or super-infection with hepatitis delta virus (hdv) may worsen the liver disease and complicate treatment possibilities. |
| PubMedID- 24444423 | The presence of a co-infection with hepatitis d virus (hdv) was excluded serologically. |
| PubMedID- 22246830 | Co-infection with hepatitis delta virus (hdv) and hepatitis b virus (hbv) has been shown to be associated with a more severe form of acute and chronic hepatitis. |
| PubMedID- 25345373 | Background: infection with hepatitis delta virus (hdv) affects about 6 to 14.5% of patients coinfected with human immunodeficiency virus type-1 (hiv-1) and hepatitis b virus (hbv), showing a more aggressive clinical course compared to hiv negative population. |
| PubMedID- 23161433 | Using heparin binding and in vitro infection assays with hepatitis d virus as a surrogate for hbv, we established that hs binding is mediated by the agl. |
| PubMedID- 23874760 | In this study, the exclusion criteria included co-infection with hcv, hepatitis d virus, hepatitis g virus and/or human immunodeficiency virus, other autoimmune liver disease, hepatocellular carcinoma, liver transplantation and metabolic liver disease. |
| PubMedID- 25861318 | infection with hepatitis delta virus (hdv) is a major health problem, at least in some regions of the world. |
| PubMedID- 22956751 | infection with hepatitis delta virus (hdv) always occurs in association with hepatitis b virus (hbv) and is a cause of significant morbidity and mortality. |
| PubMedID- 24658127 | Chronic infection with the hepatitis delta virus (hdv) is a risk factor for cirrhosis and hepatocellular carcinoma (hcc), but little is known whether the outcome of hepatitis is predicted by serum markers of hdv and hepatitis b virus (hbv) infection. |
| PubMedID- 26464754 | Chronic infection with hepatitis delta virus (hdv) has lately regained clinical importance because of the recent evidence of increasing prevalence in several european countries, due to immigration from highly endemic areas. |
| PubMedID- 26257166 | Methods: patients at low risk of recurrence were eligible for hbig discontinuation (fulminant hbv hepatitis, co-infection with hepatitis d virus, and hepatitis b e antigen-negative cirrhotic patients with hbv dna levels <300 copies/ml). |
Page: 1